Carolin Werkman

Carolin Werkman,

Department: Pharmacotherapy & Translational Research
Business Phone: (407) 313-7014
Business Email: c.werkman@ufl.edu

Publications

2024
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation.
Antimicrobial agents and chemotherapy. 68(3) [DOI] 10.1128/aac.01399-23. [PMID] 38329330.
2024
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics.
Antimicrobial agents and chemotherapy. 68(2) [DOI] 10.1128/aac.01393-23. [PMID] 38169309.
2022
KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib.
Cancer diagnosis & prognosis. 2(5):525-532 [DOI] 10.21873/cdp.10137. [PMID] 36060015.
2021
Combating Multidrug-Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational Modeling.
Clinical pharmacology and therapeutics. 109(4):1000-1020 [DOI] 10.1002/cpt.2205. [PMID] 33576025.
2021
In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach.
Breast cancer (Dove Medical Press). 13:87-105 [DOI] 10.2147/BCTT.S292161. [PMID] 33628047.
2020
First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.
Antimicrobial agents and chemotherapy. 65(1) [DOI] 10.1128/AAC.01956-20. [PMID] 33106266.
2019
Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy-apoptosis crosstalk pathway.
Breast cancer (Dove Medical Press). 11:231-241 [DOI] 10.2147/BCTT.S211030. [PMID] 31839713.

Contact Details

Phones:
Business:
(407) 313-7014
Emails:
Business:
c.werkman@ufl.edu
Addresses:
Business Mailing:
6550 SANGER RD
ORLANDO FL 32827